Paklitaksel 99,0%

Paclitaxel is a monomer diterpenoid compound extracted from Natural Plant Paclitaxel bark, is a kind of complex secondary metabolites, is currently understood only a drug can promote microtubule polymerization and stability of microtubules have been aggregated. Isotope tracing showed that paclitaxel was bound only to polymerized microtubules, not to the polymerized tubulin two. Cell contact paclitaxel after the accumulation of a large number of microtubules in cells, which interfere with microtubule accumulation of various cellular functions, especially the cell division stop in mitosis, blocking the normal cell division

Mahsulot nomi: Paklitaksel  99 .0%

Shakli: Oq kristal chang
Xususiyatlar: 99%

Test usuli: HPLC

CAS soni: 33069-62-4

Molekulyar Formula: C47H51NO14

Moddadan :760 mmHg da 957,115 ° C
853,91: molekulyar og'irligi,
GMO Status: GMO Free

Paket: 25kgs Gost So'nggi fıçılar ichida

Saqlash: salqin, quruq joyda ochilmagan holda saqlansin kuchli yorug'lik yuz saqlang

Raf umri: ishlab chiqarish boshlab 24 oy

Function:

1.Paclitaxel asosan tuxumdon va ko'krak bezi saratoni, o'pka saratoni, kolorektal saraton, melanoma, bosh va bo'yin saraton, limfoma uchun qo'llaniladi, va u ham miya o'smalari muayyan ta'sir bor.

2.It mikrotübül polimerlanish va mikrotübül polimerlanish targ'ib mumkin barqarorlik dorilar hisoblanadi.
3.There paklitaksel ta'sir so'ng hujayralardagi mikrotübüllerin bir qator to'plangan bo'ladi, hujayra vazifalari bilan mikrotübüller to'sqinlik to'planishi, xususan, normal hujayra bo'linishi to'sib, mitoz hujayra bo'linishi stoped.

Application:

tuzilishi o'rganishda foydalaniladigan va kanallari ichiga microtubles funktsiyasi. Paklitaksel endi o'pka, tuxumdon, ko'krak saratoni, bosh va bo'yin saraton, va Kaposhi ning sarkomu advanc Ed shakllari bilan davolash bemorlarning uchun ishlatiladi. Paklitaksel saraton kimyoterapiya ishlatiladigan bir mitoz inhibitörüdür.